Many countries kept doing this by buying dragon’s vaccine

Beijing. China, which is engaged in increasing its soft power by sending its corona vaccine across the world, has suffered a major setback. Now many countries are turning to the vaccine of Western countries instead of buying its vaccine. According to a report, now many countries of the world are giving priority to vaccines like Pfizer and Moderna. In fact, these countries fear that the dragon’s vaccine will not work against the delta variant. This is the reason why countries that had previously ordered the Chinese vaccine are also now turning to the American vaccine.

China introduced vaccination through its sinoform vaccine in countries in Asia, Latin America and the Middle East. But now vaccine exports have come down badly. According to the data, there has been a 21 percent decrease in vaccine exports in the month of August. This figure was increasing continuously since December 2020.
An expert from the University of Hong Kong says that initially people chose what they could achieve. But now time is passing. Common people are also becoming aware about the actual efficacy of the vaccine. Now people are beginning to understand that not all vaccines are equal in terms of efficacy.

According to the information, the efficacy rate of China’s vaccine ranges from 50 to 80 percent. But it doesn’t stand up to Pfizer’s mRNA vaccine. Just a few days ago there was news that Brazil will no longer import China’s vaccine.
Actually, China has been using vaccine diplomacy as its strength till now. American vaccines Pfizer and Moderna are expensive. Being expensive, it was easy for rich countries to buy them. In such a situation, China chose those countries which are middle-income or poor. But now the Chinese vaccine is being denied in these countries.
Another reason is that questions have always been raised about the trial and data of the Chinese vaccine. It has been said that China did not properly present the data of its vaccine to the world. After the global effect of the delta variant, now the importance of vaccine data and its efficacy is increasing in the countries of the world. in this matter